Cardiorenal syndrome : mechanisms, risk, and treatment /

Saved in:
Bibliographic Details
Imprint:Milan : Springer, c2010.
Description:1 online resource (xv, 396 p.) : ill.
Language:English
Subject:
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/8895543
Hidden Bibliographic Details
Other authors / contributors:Berbari, Adel E.
Mancia, Giuseppe.
ISBN:9788847014633 (electronic bk.)
8847014638 (electronic bk.)
Notes:Includes bibliographical references and index.
Description based on print version record.
Summary:Chronic kidney disease with a worldwide prevalence of 10% in the general population is emerging as a major public health priority. Renal dysfunction is associated with a high risk for cardiovascular complications. The relationship between renal insufficiency and cardiovascular disease, termed the cardiorenal syndrome exists whether impairment of renal function is a consequence of primary renal parenchymal disease or primary heart disease. This book provides a comprehensive update analysis of our current understanding of the cardiorenal syndrome including epidemiology pathophysiologic mechanism.
Other form:Print version: Cardiorenal syndrome. Milan : Springer, c2010 9788847014626
Table of Contents:
  • Links between chronic kidney disease and cardiovascular disease: a bidirectional relationship
  • Cardiorenal versus renocardiac syndrome
  • Non-pressure-related deleterious effects of excessive dietary sodium
  • Regulation of vascular and renal cells by common mediators in health and disease: role of the renin-angiotensin system in the pathophysiology of hypertension and cardiovascular disease
  • Cardiorenal continuum
  • Definition and classification of stages of chronic kidney disease: screening for chronic kidney disease
  • Cardiovascular disease risk factors in chronic kidney disease: traditional, nontraditional and uremia-related threats
  • Increased levels of urinary albumin: a cardiovascular risk factor and a target for treatment
  • Microalbuminuria and kidney disease: an evidence-based perspective
  • Cardiometabolic syndrome
  • Diabetes mellitus: is the presence of nephropathy important as a cardiovascular risk factor for cardioneral syndrome?
  • Cardiovascular disease: coronary artery disease and coronary artery calcification
  • Cardiomyopathy in chronic kidney disease and in end-stage renal disease
  • Pathophysiological mechanisms and prognostic significance of renal functional impairment in cardiac patients
  • Stroke
  • Uremic toxins
  • Endothelial dysfunction, nitric oxide bioavailability, and asymmetric dimethyl arginine
  • Pathophysiologic link between artherosclerosis and nephrosclerosis
  • Aortic stiffness, kidney disease, and renal transplantation
  • Disturbed calcium-phosphorus metabolism/arterial calcifications: consequences on cardiovascular function and clinical outcome
  • Role of neurohormonal activation in the pathogenesis of cardiovascular complications in chronic kidney disease
  • Impaired autonomic blood pressure and blood volume control in chronic renal failure
  • Role of novel biomarkers in chronic kidney disease: urotensin II
  • Role of novel biomarkers in chronic kidney disease: renalase
  • Diabetic kidney disease
  • Nondiabetic kidney disease
  • Approaches in the management of patients with chronic kidney disease and cardiovascular disease
  • Trends in the management of cardiac patients with renal functional impairment.